Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 9/20 | 0.68 |
| ▸ | HTR2B | P41595 | 2/20 | 0.44 |
| ▸ | HTR7 | P34969 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.44 |
| ▸ | DHODH | Q02127 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30779382 | 1.00 | ALOX5 (0.68) | ALOX5HTR2BHTR7MAPTGAA | |
| SCHEMBL22484791 | 0.92 | ALOX5 (0.52) | ALOX5HTR2BHTR7MAPTGAA | |
| Bicarbonate SCHEMBL6265696 | 0.91 | ALOX5 (0.62) | ALOX5HTR2BHTR7MAPTGAA | |
| Phenoxazine SCHEMBL6846406 | 0.90 | ALOX5 (0.77) | ALOX5HTR2BHTR7MAPTGAA | |
| Phenoxazine SCHEMBL18770789 | 0.85 | ALOX5 (0.85) | ALOX5HTR2BHTR7MAPTGAA | |
| SCHEMBL24141298 | 0.85 | ALOX5 (0.53) | ALOX5HTR2BHTR7MAPTGAA | |
| Phenoxazine SCHEMBL29355714 | 0.82 | ALOX5 (1.00) | ALOX5HTR2BHTR7MAPTGAA | |
| Phenoxazine SCHEMBL28844098 | 0.82 | ALOX5 (1.00) | ALOX5HTR2BHTR7MAPTGAA | |
| Phenoxazine SCHEMBL6310178 | 0.82 | ALOX5 (1.00) | ALOX5HTR2BHTR7MAPTGAA | |
| Phenoxazine SCHEMBL7862 | 0.82 | ALOX5 (1.00) | ALOX5HTR2BHTR7MAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3397718-A1 | FLUORESCENT PARTICULATE MATERIAL | L'Oréal (FR) | 2018-11-07 | — | — | EP | claimed |
| WO-2017114877-A1 | FLUORESCENT PARTICULATE MATERIAL | L'OREAL (FR) | 2017-07-06 | — | — | WO | claimed |
| US-20160145214-A1 | New Family of Discriminating Molecules for Neutron and Gamma Rays and Ionic Liquids | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2016-05-26 | — | — | US | claimed |
| EP-2976330-A1 | NEW FAMILY OF DISCRIMINATING MOLECULES FOR NEUTRON AND GAMMA RAYS AND IONIC LIQUIDS | Centre National de la Recherche Scientifique (C.N.R.S.) (FR) | 2016-01-27 | — | — | EP | claimed |
| EP-2638126-B1 | NEGATIVE DISPERSION RETARDATION PLATE AND ACHROMATIC CIRCULAR POLARIZER | CRYSOPTIX KK (JP) | 2015-02-18 | — | — | EP | claimed |
| WO-2014147078-A1 | NEW FAMILY OF DISCRIMINATING MOLECULES FOR NEUTRON AND GAMMA RAYS AND IONIC LIQUIDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S) (FR) | 2014-09-25 | — | — | WO | claimed |
| EP-1781675-B1 | PHOSPHONATE FLUORESCENT DYES AND CONJUGATES | EPOCH BIOSCIENCES INC (US) | 2014-03-26 | — | — | EP | claimed |
| EP-2331655-B1 | COMPOSITION OF ORGANIC COMPOUNDS, OPTICAL FILM AND METHOD OF PRODUCTION THEREOF | CRYSOPTIX KK (JP) | 2013-07-03 | — | — | EP | claimed |
| JP-2012500860-A | — | — | 2012-01-12 | — | — | JP | claimed |
| US-7671218-B2 | Phosphonate fluorescent dyes and conjugates | Elitech Holdings B.V. (NL) | 2010-03-02 | — | — | US | claimed |
| WO-2006020947-A2 | PHOSPHONATE FLUORESCENT DYES AND CONJUGATES | EPOCH BIOSCIENCES, INC. (US) | 2006-02-23 | — | — | WO | claimed |
| WO-2006008239-A2 | LUMINESCENT SILICON OXIDE FLAKES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-01-26 | — | — | WO | claimed |
| US-20050176066-A1 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-08-11 | — | — | US | claimed |
| US-20050171340-A1 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES, INC. (US) | 2005-08-04 | — | — | US | claimed |
| US-20050159606-A1 | Compounds and methods for fluorescent labeling | EPOCH BIOSCIENCES, INC. (US) | 2005-07-21 | — | — | US | claimed |
| WO-2005040357-A2 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES, INC. (US) | 2005-05-06 | — | — | WO | claimed |
| EP-1466176-A2 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | Epoch Biosciences, Inc. (US) | 2004-10-13 | — | — | EP | claimed |
| US-20030152518-A1 | Detection by increased uptake of fluorophore glucose or deoxyglucose conjugates in cancerous and pre-cancerous cells relative to normal cells. | THRESHOLD PHARMACEUTICALS, INC. | 2003-08-14 | — | — | US | claimed |
| WO-2003059149-A2 | METHODS FOR CANCER IMAGING | THRESHOLD PHARMACEUTICALS, INC. (US) | 2003-07-24 | — | — | WO | claimed |
| WO-2003023357-A2 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | EPOCH BIOSCIENCES, INC. (US) | 2003-03-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030152518-A1 | Detection by increased uptake of fluorophore glucose or deoxyglucose conjugates in cancerous and pre-cancerous cells relative to normal cells. | SLC2A1, SLC2A4, SLC2A8 | ALOX5 4375/4885HTR2B 3390/4885HTR7 1952/4885 |
| US-20050176066-A1 | Compounds and methods for fluorescent labeling | HLCS, GLB1, TUBB | ALOX5 1685/4885HTR2B 1820/4885HTR7 1303/4885 |
| US-20050171340-A1 | COMPOUNDS AND METHODS FOR FLUORESCENT LABELING | HLCS, GLB1, TUBB | ALOX5 1685/4885HTR2B 1820/4885HTR7 1303/4885 |
| US-20160145214-A1 | New Family of Discriminating Molecules for Neutron and Gamma Rays and Ionic Liquids | XRCC5, XRCC6, KPNA3 | ALOX5 4669/4885HTR2B 4764/4885HTR7 4597/4885 |
| US-20050159606-A1 | Compounds and methods for fluorescent labeling | TFEB, HLCS, PFAS | ALOX5 2235/4885HTR2B 1486/4885HTR7 1032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.